Member
Providers
Shop For a Plan

Important Updates Regarding Coronavirus COVID-19

• Posted by Provider Relations

As an important resource for providers, we encourage you to access the information on Fidelis Care’s provider portal at providers.fideliscare.org. On the portal, you can:

• check claim status
• confirm member eligibility and benefits
• submit authorization requests
• check on the status of an authorization
• view provider remittance advice

Using these tools and resources will provide you with the information you need, 24/7, and help to reduce anticipated call volume and wait times for our Provider Call Center.

COVID-19 Coverage as of October 1, 2024

 

 

Medicaid/CHP/HARP

Essential Plan

Marketplace

Medicare

 

Immunizations

Covered with no cost-sharing when provided by a participating provider.

 

 

Not covered out of network.

Covered with no cost-sharing when provided by a participating provider.

 

 

Not covered out of network.

Covered with no cost-sharing when provided by a participating provider.

 

 

Not covered out of network.

Covered with no cost-sharing when provided by a participating or a non-participating provider.

 

 

Prior Authorization not required.

 

In-Office Testing

 

Covered with no cost-sharing when provided by a participating provider.

 

 

Not covered out of network.

Covered with cost-sharing effective 10/1/24, when provided by a participating provider.

 

 

Not covered out of network.

Covered with cost-sharing when provided by a participating provider.

 

 

Not covered out of network.

Covered with cost-sharing when provided by a participating or a non-participating provider.

 

 

Prior Authorization not required.

Specimen collection and high throughput testing is not covered. For Medicaid enrollees, there is FFS reimbursement effective 5/12/23, for PCR, antigen, multiplex, and antibody tests For Marketplace enrollees, office visit cost-sharing has been reinstated. All other testing codes will be covered until 9/30/24 across all LOBs.

 

Over-the Counter Tests

Medicaid/HARP - Not covered.

CHP - Up to 2 OTC tests every 30 days.

Up to 8 OTC tests per month covered with cost-sharing.

Not covered.

Covered through Medicare FFS (fee for service).

 

COVID-19 Treatment

Covered with no cost-sharing when provided by a participating.

 

Out of network coverage requires prior authorization.

Covered with cost-sharing effective 10/1/24, when provided by a participating.

 

Not covered out of network, unless in an Emergency Department in a hospital setting.

Covered with cost-sharing when provided by a participating provider.

 


Not covered out of network.

Covered with cost-sharing when provided by a participating provider.

  


Out of network coverage dependent on plan.

 

Telemedicine

Telemedicine is covered with no cost-sharing when provided by a participating provider.

 

 

 

 

Not covered out of network.

Covered with cost-sharing effective 10/1/24, when provided by a participating provider.

 

 

 

  

Not covered out of network.

Telemedicine rendered via Fidelis Care’s Telemedicine Program is covered with no cost-sharing.   Telemedicine by other participating providers is covered with cost-sharing.

 

 

Not covered out of network.

Telemedicine* is covered with no cost-sharing when provided by a participating provider.

 

Not covered out of network.

 

* As of 5/12/2023, Medicare will no longer cover codes “99441” through “99443” for telemedicine.

 

 

Vaccine Counseling : Effective 5/12/2023, Medicaid, Essential Plan, and Marketplace members under the age of 21 are covered as a standalone service, while members 21 years old and older are not separately reimbursable and should be included in the E&M.

Coding – Updated May 1, 2025

Fidelis Care has updated our claims systems to reflect the codes currently reimbursable across all lines of business.
Coding - Updated May 1, 2025

Code Type

Code

Effective

Testing (PCR)

U0001

02/04/2020

Testing (PCR)

U0002

5/12/2023

Testing (PCR)

87635

5/12/2023

Testing (Infectious Disease)

0202U

5/20/2020

Testing (Infectious Disease)

0225U

8/10/2020

Testing (Infectious Disease)

0240U

10/6/2020

Testing (Infectious Disease)

0241U

10/6/2020

Testing (Antigen)

87426

5/12/2023

Testing (Antigen)

87811

5/12/2023

Testing (Antigen)

0223U

6/25/2020

Testing (Antigen)

0224U

6/25/2020

Testing (sVNT)

0226U

8/10/2020

Testing

86413

9/8/2020

Testing (Multiplex)

87428

5/12/2023

Testing (Multiplex)

87636

5/12/2023

Testing (Multiplex)

87637

5/12/2023

Testing (Antibody)

86328

5/12/2023

Testing (Antibody)

86769

5/12/2023

Mutation identification SARS CoV-2

87913

2/21/2022

Screening (Neutralizing Antibody)

86408

8/10/2020

Screening (Neutralizing Antibody)

86409

8/10/2020

Injection, Remdesivir, 1MG

J0248

10/1/2024

Genentech Monoclonal - Tocili Injection

Q0249

6/24/2021

Genentech Monoclonal - Tocili 1st Infusion

M0249

6/24/2021

Genentech Monoclonal - Tocili 2nd Infusion

M0250

6/24/2021

Covid-19 Convalescent Plasma Infusion

C9507

12/28/2021

NEW – Novavax Covid-19 Vaccine, Adjuvanted, Ages 18 years and older

91304

7/13/2022

Immunization administration by intramuscular (IM) injection of SARS-CoV-2 (COVID-19) vaccine, single dose

90480

09/11/2023

Pfizer-BioNTech SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose

91318

09/11/2023

Pfizer-BioNTech SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose

91319

09/11/2023

Pfizer-BioNTech SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose

91320

09/11/2023

Moderna SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose

91321

09/11/2023

Moderna SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose

91322

09/11/2023